This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (24)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Rheumatology  • Osteoporosis  • Women's Health  • Women's Health, Other  • Randomized Controlled Trial  • Alert me on articles by topic  Social Bookmarking   What's this?

Clinical Applications

David W. Bates, MD,MSc; Dennis M. Black, PhD; Steven R. Cummings, MD

JAMA. 2002;288:1898-1900.

Osteoporosis represents a difficult problem for physicians because, although many diagnostic tests are available, interpreting their results is not straightforward. As a result, many patients, even those with clear indications such as long-term steroid therapy or vertebral fractures on radiography, do not get screened or treated. Current evidence-based guidelines recommend screening for all white women older than 65 years and not already receiving an osteoporosis treatment and for many nonwhite women. For postmenopausal women who are younger than 65 years and have strong risk factors for osteoporosis, screening may also be beneficial. The optimal testing strategy depends on what is available locally. The best role for follow-up testing is still being defined, and interpretation of such testing is tricky. Reports of results can be hard to understand; a randomized controlled trial of clearer reports increased testing and decreased confusion about the meaning of test results. Densitometry might be more effectively used in practice if strategies such as having patients fill out a short questionnaire to assess for risk factors or creating a nurse-based system were used to identify patients. Clinicians need better approaches for identifying patients most likely to benefit from screening, systems that facilitate their application, and test results that are easy to interpret.

Author Affiliations: Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, and the Center for Applied Medical Information Systems Research, Partners Healthcare Systems, and Harvard Medical School, Boston, Mass (Dr Bates); and the UCSF Coordinating Center, Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco (Drs Black and Cummings).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

Clinical Use of Bone Densitometry: Scientific Review
Steven R. Cummings, David Bates, and Dennis M. Black
JAMA. 2002;288(15):1889-1897.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Phenotyping and genetic studies of 357 consecutive patients presenting with premature ovarian failure
Bachelot et al.
Eur J Endocrinol 2009;161:179-187.
ABSTRACT | FULL TEXT  

Pentosidine and Increased Fracture Risk in Older Adults with Type 2 Diabetes
Schwartz et al.
J. Clin. Endocrinol. Metab. 2009;94:2380-2386.
ABSTRACT | FULL TEXT  

A 55-Year-Old Woman With Osteopenia
Cummings
JAMA 2006;296:2601-2610.
ABSTRACT | FULL TEXT  

Longitudinal Changes in Forearm Bone Mineral Density in Women and Men Aged 45-84 Years: The Tromso Study, a Population-based Study
Emaus et al.
Am J Epidemiol 2006;163:441-449.
ABSTRACT | FULL TEXT  

Screening for Osteoporosis
Raisz
NEJM 2005;353:164-171.
FULL TEXT  

Bone Density Screening: A New Level of Evidence?
Cummings
ANN INTERN MED 2005;142:217-219.
FULL TEXT  

Classification Algorithms for Hip Fracture Prediction Based on Recursive Partitioning Methods
Jin et al.
Med Decis Making 2004;24:386-398.
ABSTRACT